Skip to main content

Celularity Inc - Class A

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Did you know?

CELU's revenue grew at a 3.9% CAGR over the last 6 years.

Current Price

$0.98

+2.83%
Profile
Valuation (TTM)
Market Cap$27.88M
P/E-0.30
EV
P/B
Shares Out28.33M
P/Sales1.05
Revenue$26.55M
EV/EBITDA

Celularity Inc - Class A (CELU) Dividends

Dividend Overview

Dividend Yield

Dividend / Share

Key Metrics

Market Cap

$27.88M

P/E Ratio

-0.30

Forward P/E

EPS

$-3.59

PEG Ratio

-0.01

Book Value

$-1.34

Dividend Yield

Profit Margin

-345.45%

ROE

Dividend History

Dividend Safety

CELU Dividend Analysis

Celularity Inc - Class A (CELU) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -0.30. Profit margin: -345.45%. Free cash flow: $-13.25M. This page shows Celularity Inc - Class A's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Celularity Inc - Class A's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.